8-K Summary: Beam Therapeutics Inc.

Event Date: November 4, 2025

Key Filing Detail:

• The Company furnished a Form 8-K to announce the release of its financial results for the fiscal quarter ended September 30, 2025.
• The detailed financial performance metrics are contained within Exhibit 99.1 (Press Release).

Investors should review Exhibit 99.1 for specific revenue, EPS, R&D spend, and cash runway information for Q3 2025.

• The report was signed by CEO John Evans.
• *Note: This 8-K only references the release of results; the actual financial data is i